PNTG · XBRL financial data

The Pennant Group financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (PNTG's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	140	146*	157	169	181	189*	210	220	229	289*	285	298
Selling, general and administrative	9	10*	11	12	13	14*	15	18	19	19*	20	22
Operating income (loss)	7	8*	9	10	11	9*	13	12	10	17*	17	17
Interest expense	1	2*	2	2	3	1*	1	1	1	3*	3	3
Other income (expense)	(0)	0*	0	(0)	0	0*	(0)	0	0	0*	(0)	1
Income tax expense (benefit)	1	2*	2	2	1	2*	3	3	3	4*	4	4
Net income (loss)	4	4*	5	6	6	6*	8	7	6	9*	9	9
Earnings per share, basic USD per share	0.15	0.15*	0.16	0.19	0.20	0.17*	0.23	0.21	0.18	0.25*	0.25	0.26
Earnings per share, diluted USD per share	0.15	0.14*	0.16	0.18	0.20	0.16*	0.22	0.20	0.17	0.24*	0.24	0.25
Weighted average shares, basic millions of shares	30	30*	30	30	30	34*	34	35	35	35*	35	35
Weighted average shares, diluted millions of shares	30	30*	30	31	31	35*	35	35	35	35*	36	36

Fiscal quarters (PNTG's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	3	6	3	3	4	24	5	14	2	17	5	15
Accounts receivable	59	61	71	76	84	81	95	96	96	123	123	133
Prepaid and other current assets	9	13	13	15	13	17	24	17	16	27	25	35
Total current assets	72	80	87	94	102	123	124	127	114	167	153	184
Property and equipment, net	28	29	41	41	42	43	44	53	56	61	64	75
Right-of-use asset	263	263	259	267	265	271	278	274	274	276	273	286
Goodwill	86	91	107	110	129	129	155	157	162	237	237	236
Total assets	520	540	578	602	647	680	744	751	754	968	956	1,037
Accounts payable	12	11	13	15	16	19	19	19	22	25	23	26
Current portion of long-term debt	—	—	—	—	—	0	—	—	—	5	5	5
Total current liabilities	69	72	75	84	91	102	88	105	109	147	129	152
Lease liability, non-current	250	249	244	252	249	253	260	256	255	254	251	263
Total liabilities	381	394	414	429	459	368	421	418	411	594	567	633
Retained earnings	30	35	40	45	51	57	65	72	78	87	95	104
Total liabilities and equity	520	540	578	602	647	680	744	751	754	968	956	1,037
Common shares outstanding (cover page) millions of shares	30	30	30	30	34	34	34	35	35	35	35	35

Fiscal quarters (PNTG's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	4	4*	5	6	6	6*	8	7	6	9*	9	9
Stock-based compensation	1*	1*	1	2*	2*	2*	2	2*	2*	2*	3	3*
Depreciation and amortization	1*	1*	1	1*	1*	2*	2	2*	2*	2*	3	3*
Net cash from operating activities	12*	5*	1	10*	8*	21*	(21)	35*	14*	21*	(3)	22*
Purchases of property and equipment	2*	2*	3	2*	1*	3*	2	3*	3*	4*	5	6*
Net cash from investing activities	(6)*	(13)*	(24)	(10)*	(33)*	(4)*	(50)	(10)*	(15)*	(153)*	(5)	(40)*
Net cash from financing activities	(5)*	10*	20	(1)*	27*	4*	53	(15)*	(11)*	147*	(3)	28*
Net change in cash	1*	3*	(3)	0*	1*	20*	(19)	9*	(12)*	15*	(12)	10*

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Pennant Group	15	298	22*	34.9M	—	Q2 FY26 10-QJun 30, 2026
Omada Health	222	88	4*	61.2M	—	Q2 FY26 10-QJun 30, 2026
LifeStance Health Group	226	435	100*	382.1M	—	Q2 FY26 10-QJun 30, 2026
U S Physical Therapy	25	214	34*	14.9M	—	Q2 FY26 10-QJun 30, 2026
GeneDx Holdings	60	114	(29)*	29.8M	4.6 quarters	Q2 FY26 10-QJun 30, 2026
Privia Health Group	412	not reported	1.1*	127.7M	—	Q2 FY26 10-QJun 30, 2026
Talkspace	39	62	11*	165.8M	—	Q2 FY26 10-QJun 30, 2026
Strata Critical Medical	35	74	9.5*	89.3M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.